Cardio Catch-Up: Boston Scientific Moves Forward With Cryoablation In Parallel With PFA

Medtech Insight’s Cardiovascular Catch-Up highlights recent news on cardiovascular tech innovations that you may have missed. This edition focuses on FROZEN AF, the pivotal trial of Boston Scientific's POLARx cryoablation system. New results from the trial were presented at the Heart Rhythm 2023 meeting in New Orleans in May.

polar bear
• Source: Shutterstock

Results from the single-arm FROZEN AF study of Boston Scientific’s POLARx cryoablation system met the safety and effectiveness endpoints and will support a premarket approval application to the FDA.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Cardiology

More from Device Area